Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV
- 1 December 1999
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 13 (18) , 2599-602
- https://doi.org/10.1097/00002030-199912240-00018
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Human Immunodeficiency Virus Load in Breast Milk, Mastitis, and Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1999
- Oral transmission of HIVAIDS, 1998
- High Incidence of Early Postnatal Transmission of Human Immunodeficiency Virus Type 1 in Bangui, Central African RepublicThe Journal of Infectious Diseases, 1998
- Antiviral Effects of Milk Proteins: Acylation Results in Polyanionic Compounds with Potent Activity against Human Immunodeficiency Virus Types 1 and 2in VitroAIDS Research and Human Retroviruses, 1996
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.Journal of Clinical Investigation, 1995
- Infective and anti-infective properties of breastmilk from HIV-1-infected womenThe Lancet, 1993
- Postnatal Transmission of Human Immunodeficiency Virus Type 1 from Mother to InfantNew England Journal of Medicine, 1991
- Regulation of Proteolysis at the Neutrophil-Substrate Interface by Secretory Leukoprotease InhibitorScience, 1990
- Tissue distribution of antileukoprotease and lysozyme in humans.Journal of Histochemistry & Cytochemistry, 1989
- Human immunodeficiency virus antibodies of IgG, IgA, and IgM subclasses in milk of seropositive mothersThe Journal of Pediatrics, 1988